The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $30.9 million contract has a period of performance through March 2031 and supports the routine pharmaceutical and medical supply needs of military treatment facilities worldwide. DMS Pharmaceutical Group holds multiple DLA contracts and delivery orders to provide a wide range of products, including epinephrine...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support military medical facilities worldwide. The IDC, valued up to $499,999,999, allows DLA to issue firm fixed-price delivery orders for common medications like antibiotics and cardiovascular drugs, as well as specialized...
The Defense Logistics Agency has awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a variety of pharmaceutical and medical supplies. The single-award contract has a potential value of up to $4,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will deliver pharmaceutical items such as flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine...
This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The single-award contract has a potential value up to $4,999,999 and runs through December 31, 2025.
Under this contract, DMS Pharmaceutical Group will provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide. This includes drugs and products such as flumazenil injection, prednisone...
The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical and medical supplies to military treatment facilities worldwide. The contract has a potential value of up to $5,999,999 and a period of performance through December 31, 2025.
Under this IDC, DMS Pharmaceutical Group will deliver a variety of pharmaceutical and medical products on a firm fixed-price basis,...
The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide.
The single-award IDC, which runs through November 30, 2026, covers a comprehensive array of pharmaceuticals, including branded and...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which runs through November 2026, covers a diverse portfolio of branded and...
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and...
The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract (IDC) valued up to $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the...
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, which runs through December 31, 2025, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide.
Key product categories include branded and generic...